Class IB-Phosphatidylinositol 3-Kinase (PI3K) Deficiency Ameliorates IA-PI3K-Induced Systemic Lupus but Not T Cell Invasion

Journal of Immunology- United States

doi 10.4049/jimmunol.176.1.589

Full Text

Abstract

Available in

Date

Authors

Publisher

The American Association of Immunologists

Related search

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Putative Phosphatidylinositol 3-Kinase (PI3K) Binding Motifs in Ovine Betaretrovirus Env Proteins Are Not Essential for Rodent Fibroblast Transformation and PI3K/Akt Activation

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Is Functionally Essential in Myxoid Liposarcoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?

Frontiers in Oncology
Cancer ResearchOncology
2018English

CREMα Suppresses Spleen Tyrosine Kinase Expression in Normal but Not Systemic Lupus Erythematosus T Cells

Arthritis & Rheumatism
2012English

Phosphatidylinositide 3-Kinase (PI3K) and PI3K-related Kinase (PIKK) Activity Contributes to Radioresistance in Thyroid Carcinomas

Oncotarget
Oncology
2016English

SRC-Induced Activation of Inducible T Cell Kinase (ITK) Requires Phosphatidylinositol 3-Kinase Activity and the Pleckstrin Homology Domain of Inducible T Cell Kinase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

PI3K Inhibitor–Induced Insulin Feedback Activates PI3K Signaling

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy